Fractyl Health, Inc. (GUTS)
Last updated: 2026-10-21 07:19:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Fractyl Health, Inc. (GUTS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.34, with a market capitalization of $18.31M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.33 to $29.34. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$18.31M | |
$1.39 | |
$174.00 | |
$1.33 | |
$1.38 | |
437.91K | |
403.67K | |
-- | |
$29.34 | |
$1.33 | |
-- | |
-- |
Fractyl Health, Inc. (GUTS) Latest Closing Stock Price
Fractyl Health, Inc. (GUTS) last closed at $1.38 as of 2026-10-20 23:45:00, unchanged from the previous close of $1.38.
During the latest regular trading session, GUTS traded between $1.33 and $174.00, with a volume of 437.91K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Fractyl Health, Inc. (GUTS) 7-Day Stock Price Change
Over the past seven days, Fractyl Health, Inc. (GUTS) moved from $4.41 to $1.34, representing a decline of 69.66% ($3.07).
The stock traded between $1.33 and $4.58 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.48 million shares, up versus the previous seven-day period, indicating higher trading activity.
GUTS 52-Week Price Position
Position in Range: 0.0%
GUTS is currently trading at $1.34, placing it 0.0% of the way from its 52-week low of $1.33 to its 52-week high of $29.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Fractyl Health, Inc. (GUTS)?
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Fractyl Health, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 73 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Fractyl Health, Inc. (GUTS) Stock on MEXC
Eligible investors can buy real shares of Fractyl Health, Inc. (GUTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Fractyl Health, Inc. (GUTS) stock price today?
2.Is GUTS stock going up or down today?
3.What is GUTS pre-market price?
4.What is GUTS after-hours price?
5.Is GUTS stock trading now?
6.Where does GUTS sit relative to its 52-week high and low?
7.What sector is Fractyl Health, Inc. in?
8.What is Fractyl Health, Inc.'s market capitalization and where is it listed?
9.How is GUTS valued in terms of P/E ratio and EPS?
10.Does Fractyl Health, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
GUTS Stock Calculator
Estimate the value between GUTS shares and USD.
GUTS Shares to USD
1.00 GUTS shares = 1.338 USD
Calculations are estimates based on the latest available price and are for reference only.


